Natera company profile

NTRA · NASDAQ · USD

Compare Natera
$319.09Change from previous close: −1.19%Absolute change: −$3.85

Close · November 13, 2026

Company profile

Natera has 6,135 employees and is headquartered in Austin, United States.

Based in Austin, Texas, Natera was founded in 2003 and develops and commercializes molecular testing services. Its portfolio includes Signatera, a personalized ctDNA blood test used for MRD assessment and early recurrence monitoring, alongside Panorama, a non-invasive prenatal test, and Prospera, a test for active rejection in patients with solid organ transplants. Its customers include independent and reference laboratories, medical centers, physician practices, research laboratories and pharmaceutical companies, reached through a direct sales force, laboratory distribution partners and Constellation licensees. The company was formerly known as Gene Security Network until it changed its name to Natera in January 2012.

In the fiscal year ended December 2025, Natera reported revenue of $2.3 billion, up 35.9% from the previous year, and a net loss of $208.2 million. The United States accounted for 98.2% of revenue that year. The company had 6,135 employees.

Company facts

Industry
Diagnostics & Research
Headquarters
13011 McCallen Pass, 78753, Austin
Employees
6,135
Chief executive
Steven Chapman
Founded
2003
Fiscal year
January - December
Listing
NTRA · NASDAQ
Currency
USD
ISIN
US6323071042
Website
natera.com

Natera and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
NateraNTRAUnited States$46.27B6,135-8.5%—
IQVIA HoldingsIQVUnited States$43.69B95,00013.9%32.3
Agilent TechnologiesAUnited States$49.04B18,20024.5%34.3
IDEXX LaboratoriesIDXXUnited States$55.48B11,00032.5%47.0
Mettler-Toledo InternationalMTDUnited States$34.59B16,60027.8%37.7
IlluminaILMNUnited States$31.3B8,60019.1%36.1

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Natera with its competitors